Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geron Corp
(NQ:
GERN
)
3.690
-0.040 (-1.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,226,235
Open
3.710
Bid (Size)
3.690 (5)
Ask (Size)
3.700 (1)
Prev. Close
3.730
Today's Range
3.550 - 3.840
52wk Range
1.680 - 4.050
Shares Outstanding
508,766,846
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 18, 2024
From
Geron Corporation
Via
Business Wire
Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday
April 12, 2024
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sharply during Friday’s session as the company reported better-than-expected...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Performance
YTD
+72.43%
+72.43%
1 Month
+7.27%
+7.27%
3 Month
+95.24%
+95.24%
6 Month
+102.75%
+102.75%
1 Year
+45.85%
+45.85%
More News
Read More
Jim Cramer: This Tech Stock Is 'Great,' Archer Aviation Is 'Too Speculative For Me'
April 11, 2024
Via
Benzinga
The Latest Analyst Ratings For Geron
April 10, 2024
Via
Benzinga
Geron Corp. (NASDAQ: GERN) Near Top of Volume Charts in Friday Trading
March 15, 2024
Via
Investor Brand Network
Geron to Participate at Upcoming Investor Conferences in April
April 03, 2024
From
Geron Corporation
Via
Business Wire
Geron Stock Doubles After Imetelstat Receives FDA Panel Approval
March 20, 2024
Via
MarketBeat
Exposures
Product Safety
Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
March 19, 2024
From
Geron Corporation
Via
Business Wire
Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
March 18, 2024
Via
Benzinga
Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
Inflation Squeezes Stocks, Bitcoin Slips To $68,000, While Commodities On Track For Best Week In Months: What's Driving Markets Friday?
March 15, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
What's Going On With Cancer Focused-Geron Stock On Friday?
March 15, 2024
Via
Benzinga
Exposures
Product Safety
Why Is Geron (GERN) Stock Up 94% Today?
March 15, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 14, 2024
Via
Benzinga
Geron Stock Is Soaring After Hours: What's Going On?
March 14, 2024
Via
Benzinga
Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS
March 14, 2024
From
Geron Corporation
Via
Business Wire
Why Geron Stock Is Falling Today
March 12, 2024
Via
Benzinga
Exposures
Product Safety
FDA Casts Doubts On Geron's Blood Cancer Drug, But Analyst Sees High Probability For Imetelstat's Potential Approval For MDS Anemia Treatment
March 12, 2024
Via
Benzinga
Exposures
Product Safety
Geron (GERN) Q4 2023 Earnings Call Transcript
February 28, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
Via
Benzinga
Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 22, 2024
From
Geron Corporation
Via
Business Wire
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
February 22, 2024
Via
Talk Markets
Geron to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
February 14, 2024
From
Geron Corporation
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.